NAD+ metabolism and its roles in cellular processes during ageing

AJ Covarrubias, R Perrone, A Grozio… - Nature reviews Molecular …, 2021 - nature.com
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme for redox reactions, making it
central to energy metabolism. NAD+ is also an essential cofactor for non-redox NAD+ …

[HTML][HTML] Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering

JR Tribble, F Hui, H Quintero, S El Hajji, K Bell… - Molecular aspects of …, 2023 - Elsevier
Glaucoma is a common, complex, multifactorial neurodegenerative disease characterized
by progressive dysfunction and then loss of retinal ganglion cells, the output neurons of the …

[HTML][HTML] Small molecule SARM1 inhibitors recapitulate the SARM1−/− phenotype and allow recovery of a metastable pool of axons fated to degenerate

RO Hughes, T Bosanac, X Mao, TM Engber… - Cell reports, 2021 - cell.com
Axonal degeneration is responsible for disease progression and accumulation of disability
in many neurodegenerative conditions. The axonal degenerative process can generate a …

[HTML][HTML] SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration

KW Ko, J Milbrandt, A DiAntonio - Journal of Cell Biology, 2020 - rupress.org
Neuroinflammation and necroptosis are major contributors to neurodegenerative disease,
and axon dysfunction and degeneration is often an initiating event. SARM1 is the central …

[HTML][HTML] Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

S Yang, JH Park, HC Lu - Molecular neurodegeneration, 2023 - Springer
Human studies consistently identify bioenergetic maladaptations in brains upon aging and
neurodegenerative disorders of aging (NDAs), such as Alzheimer's disease, Parkinson's …

[HTML][HTML] SARM1 is a multi-functional NAD (P) ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites

C Angeletti, A Amici, J Gilley, A Loreto, AG Trapanotto… - Iscience, 2022 - cell.com
Summary SARM1 is an NAD (P) glycohydrolase and TLR adapter with an essential,
prodegenerative role in programmed axon death (Wallerian degeneration). Like other NAD …

[HTML][HTML] SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling

H Liu, J Zhang, X Xu, S Lu, D Yang, C Xie, M Jia… - Theranostics, 2021 - ncbi.nlm.nih.gov
Axonal degeneration is a common pathological feature in many acute and chronic
neurological diseases such as spinal cord injury (SCI). SARM1 (sterile alpha and TIR motif …

[HTML][HTML] A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model

Y Sato-Yamada, A Strickland, Y Sasaki… - The Journal of …, 2022 - Am Soc Clin Investig
Charcot-Marie-Tooth disease type 2A (CMT2A) is an axonal neuropathy caused by
mutations in the mitofusin 2 (MFN2) gene. MFN2 mutations result in profound mitochondrial …

[HTML][HTML] Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration

R Krauss, T Bosanac, R Devraj, T Engber… - Trends in …, 2020 - cell.com
Attempts to develop neuroprotective treatments for neurodegenerative disorders have not
yet been clinically successful. Axonal degeneration has been recognized as a predominant …

The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease

MD Figley, A DiAntonio - Current opinion in neurobiology, 2020 - Elsevier
Highlights•A mechanistic understanding of the endogenous axon degeneration pathway has
emerged over the past few years.•Axonal health is maintained by a balance of survival …